Candidiasis: Clinical Trials

4 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin
1,3-β-D-glucan quantification, Micafungin - Invasive Candidiasis
Phase 4TerminatedFadoi Foundation, Italy142018-07-182021-04-12
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
Micafungin - Aspergillosis, Candidiasis
Phase 4TerminatedAstellas Pharma China, Inc.1052014-03-212024-11-07
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
Micafungin - Candidemia, Candidiasis
Phase 4TerminatedAstellas Pharma China, Inc.592013-09-262024-11-20
Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children
ciclopirox - Dermatomycoses
Phase 4TerminatedFerrer Internacional S.A.212008-10-012012-07-20

Narrower conditions

Aspergillosis (1)  ·  Candidemia (1)  ·  Candidiasis, Invasive (1)  ·  Dermatomycoses (1)  ·  Tinea (1)

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Infections (4)  ·  Mycoses (4)  ·  Invasive Fungal Infections (2)  ·  Candidiasis, Invasive (1)  ·  Fungemia (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Micafungin (3)  ·  Ciclopirox (1)

Sponsors

Astellas Pharma China, Inc. (2)  ·  Fadoi Foundation, Italy (1)  ·  Ferrer Internacional S.A. (1)

Countries

China (2)  ·  Italy (1)

Top investigators

Jose C Moreno, Prof, PhD (1)

NIH funding

2008 (1)